Financial statements Novartis Poland
Cash inflows of NOVARTIS POLAND
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Net cash from operating expenses | 15 949 946,12 | 13 181 018,73 | -5 519 851,91 | 18 736 847,68 | 9 862 883,60 | 6 848 484,66 |
| Net cash flow from investing activities | -15 792 504,66 | -13 151 846,54 | 5 545 462,89 | -18 433 304,22 | -10 278 052,80 | -6 606 876,24 |
| Net cash flow from financial activities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total net cash flow | 157 441,46 | 29 172,19 | 25 610,98 | 303 543,46 | -415 169,20 | 241 608,42 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.